Vivos Therapeutics, Inc. (VVOS)
0.0569
-0.02
(-25.13%)
USD |
NASDAQ |
Nov 19, 16:00
0.0567
0.00 (0.00%)
After-Hours: 19:36
Vivos Therapeutics Max Drawdown (5Y) : 99.89% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.89% |
| September 30, 2026 | 99.88% |
| August 31, 2026 | 99.86% |
| July 31, 2026 | 99.74% |
| June 30, 2026 | 99.73% |
| May 31, 2026 | 99.61% |
| April 30, 2026 | 99.58% |
| March 31, 2026 | 99.55% |
| February 28, 2026 | 99.42% |
| January 31, 2026 | 99.33% |
| December 31, 2025 | 99.19% |
| November 30, 2025 | 99.19% |
| October 31, 2025 | 99.19% |
| September 30, 2025 | 99.19% |
| August 31, 2025 | 99.19% |
| July 31, 2025 | 99.19% |
| June 30, 2025 | 99.19% |
| May 31, 2025 | 99.19% |
| April 30, 2025 | 99.19% |
| March 31, 2025 | 99.19% |
| February 28, 2025 | 99.19% |
| January 31, 2025 | 99.19% |
| December 31, 2024 | 99.19% |
| November 30, 2024 | 99.19% |
| October 31, 2024 | 99.19% |
| Date | Value |
|---|---|
| September 30, 2024 | 99.19% |
| August 31, 2024 | 99.19% |
| July 31, 2024 | 99.19% |
| June 30, 2024 | 99.19% |
| May 31, 2024 | 99.19% |
| April 30, 2024 | 98.98% |
| March 31, 2024 | 98.87% |
| February 29, 2024 | 98.87% |
| January 31, 2024 | 98.87% |
| December 31, 2023 | 98.87% |
| November 30, 2023 | 98.87% |
| October 31, 2023 | 98.67% |
| September 30, 2023 | 98.11% |
| August 31, 2023 | 97.40% |
| July 31, 2023 | 97.39% |
| June 30, 2023 | 96.80% |
| May 31, 2023 | 96.80% |
| April 30, 2023 | 96.80% |
| March 31, 2023 | 96.69% |
| February 28, 2023 | 96.42% |
| January 31, 2023 | 96.42% |
| December 31, 2022 | 96.42% |
| November 30, 2022 | 94.83% |
| October 31, 2022 | 93.38% |
| September 30, 2022 | 93.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Hinge Health, Inc. | -- |
| Exlites Holdings International, Inc. | 99.86% |
| Xcelerate, Inc. | 95.32% |
| Abbott Laboratories | 39.63% |
| AngioDynamics, Inc. | 82.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -129.91 |
| Beta (5Y) | 6.374 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 223.1% |
| Historical Sharpe Ratio (5Y) | -0.3478 |
| Historical Sortino (5Y) | -1.527 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.28% |